Efficacy of endostar in combination with concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of esophagus: A randomized, open-label, phase II trial

被引：0
|
作者：
Qi, Y. [1 ]
Shao, L. [1 ]
机构：
[1] Sun Yat Sen Univ, Radiat, Canc Ctr, Gansu Hosp, Lanzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.778
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
199P
引用
收藏
页码：S1551 / S1551
页数：1
相关论文
共 50 条
  • [21] Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
    Yin, Yuanxiu
    Zhou, Ziyan
    Li, Zhiru
    Shen, Mingjun
    Qin, Yating
    Yang, Chaolin
    Wang, Rensheng
    Kang, Min
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [22] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, J. G.
    Kim, D. H.
    Sohn, S. K.
    Baek, J. H.
    Chae, Y. S.
    Lee, K. B.
    Sohn, J. H.
    Park, J. S.
    Kim, J. C.
    Park, I. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 300 - 300
  • [23] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    S K Sohn
    D H Kim
    J H Baek
    S B Jeon
    Y S Chae
    K B Lee
    J S Park
    J H Sohn
    J C Kim
    I K Park
    British Journal of Cancer, 2005, 93 : 1117 - 1121
  • [24] Camrelizumab in combination with preoperative chemotherapy for locally advanced esophageal squamous cell carcinoma: A single-arm, open-label, phase II study
    Wang Feng
    Qi Yu
    Meng Xiangrui
    Fan Qingxia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [25] Phase II study of concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced squamous cell carcinoma of the oral cavity
    Adilbaev, G. -B.
    Kidirbaeva, G.
    Savhatova, A. -D.
    Turesheva, A. -O.
    Adilbay, D. -G.
    ORAL ONCOLOGY, 2011, 47 : S28 - S28
  • [26] Apatinib in Chinese patients with advanced hepatocellular carcinoma: A phase II randomized, open-label trial.
    Qin, Shukui
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy: A randomized, open-label phase II trial (ORIENT-2).
    Xu, Jianming
    Li, Yi
    Fan, Qingxia
    Shu, Yongqian
    Wu, Zhijun
    Cui, Tongjian
    Gu, Kangsheng
    Tao, Min
    Wang, Xiuwen
    Cui, Chengxu
    Xu, Nong
    Xiao, Juxiang
    Gao, Quanli
    Liu, Yunpeng
    Zhang, Tao
    Zhou, Hui
    Wang, Yan
    Xu, Linxinyu
    Ma, Zhuo
    Wang, Yanqi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Nimotuzumab combined with concurrent chemo-radiotherapy in patients with locally advanced cervical squamous cell carcinoma: A randomized, controlled, open-label, multicenter study
    Wang, J.
    Jiang, P.
    Wei, L.
    Zou, L.
    Li, X.
    Wang, C.
    Sun, X.
    Ding, L.
    Yuan, X.
    Cheng, H.
    Wu, D.
    Cai, R.
    Yin, R.
    Zhang, J.
    Qiu, H.
    Wang, T.
    Gao, K.
    Zhuo, Y.
    Zhang, Y.
    Zhao, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S518 - S519
  • [29] Camrelizumab plus concurrent chemoradiotherapy for locally advanced cervical cancer: Preliminary results of a single-arm, open-label, phase II trial
    Xiao, Y.
    Cheng, H.
    Wang, L.
    Yang, L.
    Yu, X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S805 - S805
  • [30] Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
    Chen, Jie
    Li, Chen
    Cao, Yuanjie
    Zhu, Li
    Zhang, Bailin
    You, Jinqiang
    Hou, Hailing
    Wang, Jing
    Yuan, Zhiyong
    BMC CANCER, 2022, 22 (01)
12345